Näytetään tulokset 1 - 10 / 14
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi
 Julkaisujen tiedon ikoni

A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40064-016-2920-z
Foster, Graham R.; Chayama, Kazuaki; Chuang, Wan-Long; Fainboim, Hugo; Farkkila, Martti; Gadano, Adr...
SpringerPlus2016 Julkaisujen tiedon ikoni

Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection

Vertaisarvioitu
Avoin saatavuus
DOI
10.1371/journal.pone.0155142
Waldenstrom, Jesper; Westin, Johan; Nystrom, Kristina; Christensen, Peer; Dalgard, Olav; Farkkila, M...
PLoS ONE2016 Julkaisujen tiedon ikoni

Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41591-023-02576-1
Krogvold, Lars; Mynarek, Ida Maria; Ponzi, Erica; Mørk, Freja Barrett; Hessel, Trine Witzner; Roald,...
Nature medicine2023 Julkaisujen tiedon ikoni

Treatment of persistent rhinovirus infection with pegylated interferon a2a and ribavirin in patients with hypogammaglobulinemia.

Vertaisarvioitu
Ruuskanen O; Waris M; Kainulainen L
Clinical Infectious Diseases2014 Julkaisujen tiedon ikoni

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience

Vertaisarvioitu
Avoin saatavuus
DOI
10.3109/00365521.2015.1087588
Waldenstrom, Jesper; Farkkila, Martti; Rembeck, Karolina; Norkrans, Gunnar; Langeland, Nina; Morch, ...
Scandinavian journal of gastroenterology2016 Julkaisujen tiedon ikoni

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

Vertaisarvioitu
DOI
10.3109/00365521.2013.793389
Lagging, Martin; Rembeck, Karolina; Buhl, Mads Rauning; Christensen, Peer; Dalgard, Olav; Färkkilä, ...
Scandinavian journal of gastroenterology2013 Julkaisujen tiedon ikoni

Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

Vertaisarvioitu
DOI
10.1111/j.1365-2893.2010.01303.x
Pedersen C, Alsiö Å, Lagging M, Langeland N, Färkkilä M, Buhl MR, Mørch K, Westin J, Sangfelt P, Nor...
Journal of viral hepatitis2011 Julkaisujen tiedon ikoni

Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

Vertaisarvioitu
DOI
10.1111/j.1365-2893.2010.01303.x
Pedersen C, Alsiö Å, Lagging M, Langeland N, Färkkilä M, Buhl MR, Mørch K, Westin J, Sangfelt P, Nor...
Journal of viral hepatitis2011 Julkaisujen tiedon ikoni

Impact of Obesity on the Bioavailability of Peginterferon-alpha 2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

Vertaisarvioitu
Avoin saatavuus
DOI
10.1371/journal.pone.0037521
Alsio, Asa; Rembeck, Karolina; Askarieh, Galia; Christensen, Peer Brehm; Färkkilä, Martti Antero; La...
PLoS ONE2012 Julkaisujen tiedon ikoni

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study

Vertaisarvioitu
Avoin saatavuus
DOI
10.1371/journal.pone.0179764
Dalgard, Olav; Weiland, Ola; Noraberg, Geir; Karlsen, Lars; Heggelund, Lars; Farkkila, Martti; Balsl...
PLoS ONE2017

A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40064-016-2920-z
2016

Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection

Vertaisarvioitu
Avoin saatavuus
DOI
10.1371/journal.pone.0155142
2016

Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41591-023-02576-1
2023

Treatment of persistent rhinovirus infection with pegylated interferon a2a and ribavirin in patients with hypogammaglobulinemia.

Vertaisarvioitu
2014

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience

Vertaisarvioitu
Avoin saatavuus
DOI
10.3109/00365521.2015.1087588
2016

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

Vertaisarvioitu
DOI
10.3109/00365521.2013.793389
2013

Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

Vertaisarvioitu
DOI
10.1111/j.1365-2893.2010.01303.x
2011

Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

Vertaisarvioitu
DOI
10.1111/j.1365-2893.2010.01303.x
2011

Impact of Obesity on the Bioavailability of Peginterferon-alpha 2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

Vertaisarvioitu
Avoin saatavuus
DOI
10.1371/journal.pone.0037521
2012

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study

Vertaisarvioitu
Avoin saatavuus
DOI
10.1371/journal.pone.0179764
2017